TORONTO, April 25, 2013 /CNW/ - The Medipattern Corporation ("Medipattern" or the "Company") (TSX-V: MKI.V), announced today that it has failed to reach a
negotiated settlement with its secured creditors as earlier disclosed
in a press release of the Company on March 13, 2013. The secured
creditors have filed an application for appointment of an interim
receiver pursuant to Section 47 of the Bankruptcy and Insolvency Act (Canada). The Company expects that this application will be approved
today.
About the Medipattern Corporation:
Medipattern® is an award-winning leader in the development and commercialization of
healthcare solutions that positively impact people's lives through the
prevention of disease and analysis of medical images and data.
Medipattern's Knowledge-based Informatics (MKI) platform enables
delivery of these streamlined solutions. Medipattern mHealth uses
patented prevention technologies to engage, coach and monitor people in
achieving their personalized goals. Medipattern iaHealth uses patented
pattern recognition technology to analyze medical data to aid medical
practitioners in the assessment of disease and critical anatomy. For
more information, please visit the Company's website: www.medipattern.com.
Medipattern® is registered trademarks of The Medipattern Corporation. Visualize:Vascular™ is a registered trademark of Medipattern.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: The Medipattern Corporation

<p> Jeff Collins, CEO<br/> The Medipattern Corporation<br/> (416) 744-0009 ext. 224<br/> <a href="mailto:jcollins@medipattern.com" cr="true">jcollins@medipattern.com</a> </p>